A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus
Abstract Nipah and Hendra viruses are highly pathogenic bat-borne paramyxoviruses recently included in the WHO Blueprint priority diseases list. A fully registered horse anti-Hendra virus subunit vaccine has been in use in Australia since 2012. Based on the same immunogen, the Hendra virus attachmen...
Guardado en:
Autores principales: | Thomas W. Geisbert, Kathryn Bobb, Viktoriya Borisevich, Joan B. Geisbert, Krystle N. Agans, Robert W. Cross, Abhishek N. Prasad, Karla A. Fenton, Hao Yu, Timothy R. Fouts, Christopher C. Broder, Antony S. Dimitrov |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/652276c0d46b42ed8977b0d8d12fab81 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hendra and Nipah Virus Infection in Cultured Human Olfactory Epithelial Cells
por: Viktoriya Borisevich, et al.
Publicado: (2017) -
<italic toggle="yes">Bundibugyo ebolavirus</italic> Survival Is Associated with Early Activation of Adaptive Immunity and Reduced Myeloid-Derived Suppressor Cell Signaling
por: Courtney Woolsey, et al.
Publicado: (2021) -
Structural basis for importin alpha 3 specificity of W proteins in Hendra and Nipah viruses
por: Kate M. Smith, et al.
Publicado: (2018) -
Combination therapy protects macaques against advanced Marburg virus disease
por: Robert W. Cross, et al.
Publicado: (2021) -
Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment
por: Robert W. Cross, et al.
Publicado: (2020)